https://www.clinicaltrialsregister.eu/<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"}
}
, "answeringMemberConstituency" : {"_value" : "Gosport"}
, "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"}
, "dateOfAnswer" : {"_value" : "2019-05-16", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-05-16T15:01:14.317Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-05-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Medicine: Research"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of ensuring it is made clear whenever health research is commercially funded.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1436", "label" : {"_value" : "Biography information for Paul Farrelly"}
}
, "tablingMemberConstituency" : {"_value" : "Newcastle-under-Lyme"}
, "tablingMemberPrinted" : [{"_value" : "Paul Farrelly"}
], "uin" : "253523"}
, {"_about" : "http://data.parliament.uk/resources/1126064", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1126064/answer", "answerText" : {"_value" : "Officials at the Department worked with colleagues across Government to respond to recommendations of the report by the all-party parliamentary group (APPG) on acquired brain injury. This response, which outlined the broad range of activity underway to address the issues raised by the APPG, was issued on 19 February 2019. A copy of the response is attached.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "attachment" : {"_about" : "http://data.parliament.uk/resources/1126064/answer/attachment/1", "fileName" : {"_value" : "DHSC APPG ABI Response.pdf"}
, "title" : "APPG Response"}
, "dateOfAnswer" : {"_value" : "2019-05-16", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-05-16T15:42:08.143Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-05-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Brain: Injuries"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what plans he has to establish a cross-departmental taskforce to address the issues and recommendations outlined in the report of the all-party parliamentary group on acquired brain injury entitled Acquired brain injury and neurorehabilitation - time for change.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4082", "label" : {"_value" : "Biography information for Lisa Nandy"}
}
, "tablingMemberConstituency" : {"_value" : "Wigan"}
, "tablingMemberPrinted" : [{"_value" : "Lisa Nandy"}
], "uin" : "253567"}
, {"_about" : "http://data.parliament.uk/resources/1126166", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1126166/answer", "answerText" : {"_value" : "
Departmental support for staff transitioning into retirement includes a Pre Retirement learning event, provided via Civil Service Learning, which raises awareness of available information and resources, supports proactive planning for making the most of retirement and awareness of how to claim Civil Service and state pensions.<\/p>
All staff in the Department who are part of the Civil Service Pension Scheme, have access to MyCSP, the Civil Service pension provider, which provides online resources and tools, such as the Retirement Modeller and a Pension Portal and also provides individual pension advice over the phone.<\/p>
The Department also offers and wherever possible, supports staff requests for partial retirement to support individual needs and also as a transition to future retirement.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"}
}
, "answeringMemberConstituency" : {"_value" : "Gosport"}
, "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"}
, "dateOfAnswer" : {"_value" : "2019-05-16", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-05-16T11:24:44.127Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-05-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Department of Health and Social Care: Retirement"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what support his Department provides to staff in his Department (a) in their transition to retirement and (b) to (i) maintain and (ii) increase the physical and mental wellbeing staff planning for retirement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/534", "label" : {"_value" : "Biography information for Chris Ruane"}
}
, "tablingMemberConstituency" : {"_value" : "Vale of Clwyd"}
, "tablingMemberPrinted" : [{"_value" : "Chris Ruane"}
], "uin" : "253516"}
, {"_about" : "http://data.parliament.uk/resources/1126258", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1126258/answer", "answerText" : {"_value" : "
Individual organisations should have in place their own clinical governance and ensure their clinical practices are in line with any national guidelines. It is the role of the Care Quality Commission to monitor, inspect and regulate healthcare services to make sure they meet fundamental standards of quality and safety.<\/p>
<\/p>
Healthcare professional regulators, including the General Medical Council and the Nursing and Midwifery Council, are responsible for assuring the fitness to practise of healthcare professionals, and can take action against professionals who do not meet the standards for professional conduct set by the regulators.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"}
}
, "answeringMemberConstituency" : {"_value" : "Thurrock"}
, "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"}
, "dateOfAnswer" : {"_value" : "2019-05-16", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-05-16T15:53:27.383Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-05-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Foetuses"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answers of 6 February 2019 to Question 214478 on Foetuses: Analgesics and of 26 February 2019 to Question 223137 on Abortion, whose role it is to oversee clinical practices to ensure (a) consistency of practice and (b) equality of patient advice and care.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/3958", "label" : {"_value" : "Biography information for Fiona Bruce"}
}
, "tablingMemberConstituency" : {"_value" : "Congleton"}
, "tablingMemberPrinted" : [{"_value" : "Fiona Bruce"}
], "uin" : "253557"}
, {"_about" : "http://data.parliament.uk/resources/1126266", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1126266/answer", "answerText" : {"_value" : "
The Department fully understands that maintaining access to insulin is vitally important to many people in this country.<\/p>
The Government remains committed to leaving the European Union with a deal. We have now reached agreement with the EU on an extension to the Article 50 period until 31 October at the latest, with the option to leave earlier as soon as a Withdrawal Agreement has been ratified.<\/p>
Under the terms of the Withdrawal Agreement, there will be an implementation period running till the end of 2020, during which there will be no changes to the current trading arrangements with the EU. Therefore, if the Withdrawal Agreement is ratified, the supply of medicines will continue on the same basis it does now during this period.<\/p>
Leaving without a deal remains the legal default at the end of the extension period if no Withdrawal Agreement is agreed. Therefore, as a responsible Government, we will continue to prepare to minimise any disruption to the supply of medicines and medical products in a potential \u2018no deal\u2019 scenario.<\/p>
We are continuing to work with trade bodies and other stakeholders to review the position carefully before sharing further guidance at the earliest opportunity. Stockpiled medicines were not procured by the Department as part of our \u2018no deal\u2019 plans and remain the property of medicines suppliers. On 26 April we wrote to pharmaceutical companies, including those who supply insulin, asking in the meantime, that all \u2018no deal\u2019 measures (such as stockpiles, additional buffer stocks etc) should remain in place but on hold until further guidance is available.<\/p>
We are confident that if everyone, including suppliers, freight companies, our European neighbours, and the health and care system, does what they need to do, the supply of medicines and medical products should be uninterrupted in the event we leave the EU without a deal.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"}
}
, "answeringMemberConstituency" : {"_value" : "Wimbledon"}
, "answeringMemberPrinted" : {"_value" : "Stephen Hammond"}
, "dateOfAnswer" : {"_value" : "2019-05-16", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-05-16T11:27:54.783Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-05-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Insulin"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether stocks of insulin will continue to be stockpiled to prepare for the UK leaving the EU without a deal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4634", "label" : {"_value" : "Biography information for Christine Jardine"}
}
, "tablingMemberConstituency" : {"_value" : "Edinburgh West"}
, "tablingMemberPrinted" : [{"_value" : "Christine Jardine"}
], "uin" : "253706"}
, {"_about" : "http://data.parliament.uk/resources/1126267", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1126267/answer", "answerText" : {"_value" : "
The Department fully understands that maintaining access to insulin is vitally important to many people in this country.<\/p>
The Government remains committed to leaving the European Union with a deal. We have now reached agreement with the EU on an extension to the Article 50 period until 31 October at the latest, with the option to leave earlier as soon as a Withdrawal Agreement has been ratified.<\/p>
Under the terms of the Withdrawal Agreement, there will be an implementation period running till the end of 2020, during which there will be no changes to the current trading arrangements with the EU. Therefore, if the Withdrawal Agreement is ratified, the supply of medicines will continue on the same basis it does now during this period.<\/p>
Leaving without a deal remains the legal default at the end of the extension period if no Withdrawal Agreement is agreed. Therefore, as a responsible Government, we will continue to prepare to minimise any disruption to the supply of medicines and medical products in a potential \u2018no deal\u2019 scenario.<\/p>
We are continuing to work with trade bodies and other stakeholders to review the position carefully before sharing further guidance at the earliest opportunity. Stockpiled medicines were not procured by the Department as part of our \u2018no deal\u2019 plans and remain the property of medicines suppliers. On 26 April we wrote to pharmaceutical companies, including those who supply insulin, asking in the meantime, that all \u2018no deal\u2019 measures (such as stockpiles, additional buffer stocks etc) should remain in place but on hold until further guidance is available.<\/p>
We are confident that if everyone, including suppliers, freight companies, our European neighbours, and the health and care system, does what they need to do, the supply of medicines and medical products should be uninterrupted in the event we leave the EU without a deal.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"}
}
, "answeringMemberConstituency" : {"_value" : "Wimbledon"}
, "answeringMemberPrinted" : {"_value" : "Stephen Hammond"}
, "dateOfAnswer" : {"_value" : "2019-05-16", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-05-16T11:29:34.897Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-05-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Insulin"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the amount of insulin procured before 29 March 2019 as part of preparations for the UK leaving the EU without a deal that has been (a) destroyed, (b) redistributed and (c) sold back to manufacturers.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4634", "label" : {"_value" : "Biography information for Christine Jardine"}
}
, "tablingMemberConstituency" : {"_value" : "Edinburgh West"}
, "tablingMemberPrinted" : [{"_value" : "Christine Jardine"}
], "uin" : "253707"}
, {"_about" : "http://data.parliament.uk/resources/1126283", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1126283/answer", "answerText" : {"_value" : "
My Rt. hon. Friend the Secretary of State has met with both Richard Vautrey and Helen Stokes-Lampard as representatives of the profession to discuss a range of issues, including, but not limited to, the creation of Primary Care Networks.<\/p>
<\/p>
In addition, Departmental officials have been in regular communication with both the Royal College of General Practitioners (RCGP) and the British Medical Association (BMA) throughout the development of the Primary Care Networks policy and will continue these close working relationships as the networks are implemented.<\/p>
<\/p>
The Primary Care Network Directed Enhanced Service specification, which sets out the timetable for networks, was agreed with the General Practitioners Committee and the BMA as part of negotiations on the contract for 2019/20.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "dateOfAnswer" : {"_value" : "2019-05-16", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-05-16T15:44:50.49Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-05-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Primary Care Networks"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what discussions he had with (a) the British Medical Association, (b) the Royal College of General Practitioners and (c) other representative groups before announcing the timetable for the creation of primary care networks.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4657", "label" : {"_value" : "Biography information for Anneliese Dodds"}
}
, "tablingMemberConstituency" : {"_value" : "Oxford East"}
, "tablingMemberPrinted" : [{"_value" : "Anneliese Dodds"}
], "uin" : "253710"}
], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&AnsweringBody.=Department+of+Health+and+Social+Care&max-answer.questionFirstAnswered.=2019-05-17T13%3A51%3A35.713Z", "page" : 0, "startIndex" : 1, "totalResults" : 10608, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}